Springer Nature
Browse
13287_2020_1804_MOESM1_ESM.docx (29.29 kB)

Additional file 1 of Mesenchymal stem cells: current clinical progress in ARDS and COVID-19

Download (29.29 kB)
journal contribution
posted on 2020-07-23, 04:49 authored by Kun Xiao, Fei Hou, Xiuyu Huang, Binbin Li, Zhi Rong Qian, Lixin Xie
Additional file 1 : Table S1. Summary of the therapeutic benefits of MSCs in current preclinical models of experimental ARDS/ALI. Table S2. Ongoing and new studies of mesenchymal stem cell-based therapies for COVID-19 pneumonia.

History

Usage metrics

    Stem Cell Research & Therapy

    Categories

    Keywords

    Acute respiratory distress syndromeCell therapyMesenchymal stem cellsCOVID-19Clinical trials

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC